{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:10:16Z","timestamp":1762506616295},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,22]],"date-time":"2015-08-22T00:00:00Z","timestamp":1440201600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0879-7","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T13:42:41Z","timestamp":1440164561000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Reason","family":"Wilken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin Shang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria R.","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoungmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falin B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forum","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanual","family":"Maverakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,22]]},"reference":[{"issue":"11","key":"879_CR1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","volume":"68","author":"A Lyell","year":"1956","unstructured":"Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol. 1956;68(11):355\u201361.","journal-title":"Br J Dermatol"},{"issue":"19","key":"879_CR2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331(19):1272\u201385.","journal-title":"N Engl J Med"},{"issue":"12","key":"879_CR3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2133.1967.tb11434.x","volume":"79","author":"A Lyell","year":"1967","unstructured":"Lyell A. A review of toxic epidermal necrolysis in Britain. Br J Dermatol. 1967;79(12):662\u201371.","journal-title":"Br J Dermatol"},{"issue":"1","key":"879_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2133.1979.tb03571.x","volume":"100","author":"A Lyell","year":"1979","unstructured":"Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol. 1979;100(1):69\u201386.","journal-title":"Br J Dermatol"},{"issue":"10","key":"879_CR5","first-page":"1160","volume":"10","author":"P Kasemsarn","year":"2011","unstructured":"Kasemsarn P, Kulthanan K, Tuchinda P, Dhana N, Jongjarearnprasert K. Cutaneous reactions to non-steroidal anti-inflammatory drugs. Drugs Dermatol. 2011;10(10):1160\u20137.","journal-title":"Drugs Dermatol"},{"issue":"5","key":"879_CR6","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1097\/BCR.0b013e31822ac7be","volume":"32","author":"BE Baetz","year":"2011","unstructured":"Baetz BE, Patton ML, Guilday RE, Reigart CL, Ackerman BH. Amlodipine-induced toxic epidermal necrolysis. J Burn Care Res. 2011;32(5):e158\u2013160.","journal-title":"J Burn Care Res"},{"issue":"8","key":"879_CR7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5414\/CPP48549","volume":"48","author":"V Vlahovic-Palcevski","year":"2010","unstructured":"Vlahovic-Palcevski V, Milic S, Hauser G, Protic A, Zupan Z, Reljic M, et al. Toxic epidermal necrolysis associated with carvedilol treatment. Int J Clin Pharmacol Ther. 2010;48(8):549\u201351.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"879_CR8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1345\/aph.1C284","volume":"37","author":"DA Alkurtass","year":"2003","unstructured":"Alkurtass DA, Al-Jazairi AS. Possible captopril-induced toxic epidermal necrolysis. Ann Pharmacother. 2003;37(3):380\u20133.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"879_CR9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archderm.1991.01680050083008","volume":"127","author":"E Schopf","year":"1991","unstructured":"Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome: an epidemiologic study from West Germany. Arch Dermatol. 1991;127(6):839\u201342.","journal-title":"Arch Dermatol"},{"issue":"1","key":"879_CR10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs: the EuroSCAR-study. J Invest Dermatol. 2008;128(1):35\u201344.","journal-title":"J Invest Dermatol"},{"issue":"24","key":"879_CR11","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333(24):1600\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"879_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","volume":"126","author":"JC Roujeau","year":"1990","unstructured":"Roujeau JC, Guillaume JC, Fabre JP, Penso D, Flechet ML, Girre JP. Toxic epidermal necrolysis (Lyell syndrome): incidence and drug etiology in France, 1981\u20131985. Arch Dermatol. 1990;126(1):37\u201342.","journal-title":"Arch Dermatol"},{"issue":"8","key":"879_CR13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138(8):1019\u201324.","journal-title":"Arch Dermatol"},{"issue":"9","key":"879_CR14","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","volume":"123","author":"J Revuz","year":"1987","unstructured":"Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J, et al. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Arch Dermatol. 1987;123(9):1160\u20135.","journal-title":"Arch Dermatol"},{"issue":"3","key":"879_CR15","first-page":"153","volume":"42","author":"E Meneux","year":"1997","unstructured":"Meneux E, Paniel BJ, Pouget F, Revuz J, Roujeau JC, Wolkenstein P. Vulvovaginal sequelae in toxic epidermal necrolysis. J Reprod Med. 1997;42(3):153\u20136.","journal-title":"J Reprod Med"},{"issue":"4","key":"879_CR16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","volume":"116","author":"C Sotozono","year":"2009","unstructured":"Sotozono C, Ueta M, Koizumi N, Inatomi T, Shirakata Y, Ikezawa Z, et al. Diagnosis and treatment of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology. 2009;116(4):685\u201390.","journal-title":"Ophthalmology"},{"key":"879_CR17","volume-title":"Dermatology","author":"JS Bolognia","year":"2007","unstructured":"Bolognia JS, Jorizzo JL, Rapini RP. Dermatology. London: Mosby; 2007."},{"issue":"1","key":"879_CR18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1):92\u20136.","journal-title":"Arch Dermatol"},{"issue":"11","key":"879_CR19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1346-8138.1997.tb02524.x","volume":"24","author":"JC Roujeau","year":"1997","unstructured":"Roujeau JC. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol. 1997;24(11):726\u20139.","journal-title":"J Dermatol"},{"issue":"1","key":"879_CR20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","volume":"58","author":"J Schneck","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008;58(1):33\u201340.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"879_CR21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1081-1206(10)60789-2","volume":"97","author":"B Khalili","year":"2006","unstructured":"Khalili B, Bahna SL. Pathogenesis and recent therapeutic trends in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol. 2006;97(3):272\u201380. quiz 281\u2013273, 320.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"879_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.iio.0000177430.89645.6d","volume":"45","author":"AY Hynes","year":"2005","unstructured":"Hynes AY, Kafkala C, Daoud YJ, Foster CS. Controversy in the use of high-dose systemic steroids in the acute care of patients with Stevens\u2013Johnson syndrome. Int Ophthalmol Clin. 2005;45(4):25\u201348.","journal-title":"Int Ophthalmol Clin"},{"issue":"15","key":"879_CR23","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.2165\/00003495-200565150-00002","volume":"65","author":"O Faye","year":"2005","unstructured":"Faye O, Roujeau JC. Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date. Drugs. 2005;65(15):2085\u201390.","journal-title":"Drugs"},{"issue":"3","key":"879_CR24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1526-0968.2002.00409.x","volume":"6","author":"G Bamichas","year":"2002","unstructured":"Bamichas G, Natse T, Christidou F, Stangou M, Karagianni A, Koukourikos S, et al. Plasma exchange in patients with toxic epidermal necrolysis. Ther Apher. 2002;6(3):225\u20138.","journal-title":"Ther Apher"},{"issue":"1","key":"879_CR25","first-page":"24","volume":"87","author":"D Reese","year":"2011","unstructured":"Reese D, Henning JS, Rockers K, Ladd D, Gilson R. Cyclosporine for SJS\/TEN: a case series and review of the literature. Cutis. 2011;87(1):24\u20139.","journal-title":"Cutis"},{"issue":"1","key":"879_CR26","first-page":"61","volume":"23","author":"LC Zarate-Correa","year":"2013","unstructured":"Zarate-Correa LC, Carrillo-Gomez DC, Ramirez-Escobar AF, Serrano-Reyes C. Toxic epidermal necrolysis successfully treated with infliximab. J Investig Allergol Clin Immunol. 2013;23(1):61\u20133.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"879_CR27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1346-8138.2009.00616.x","volume":"36","author":"E Gubinelli","year":"2009","unstructured":"Gubinelli E, Canzona F, Tonanzi T, Raskovic D, Didona B. Toxic epidermal necrolysis successfully treated with etanercept. J Dermatol. 2009;36(3):150\u20133.","journal-title":"J Dermatol"},{"issue":"9140","key":"879_CR28","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","volume":"352","author":"P Wolkenstein","year":"1998","unstructured":"Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Boudeau S, Vaillant L, et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet. 1998;352(9140):1586\u20139.","journal-title":"Lancet"},{"issue":"10","key":"879_CR29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/archdischild-2013-304909","volume":"98","author":"F Corrick","year":"2013","unstructured":"Corrick F, Anand G. Question 2: Would systemic steroids be useful in the management of Stevens\u2013Johnson syndrome? Arch Dis Child. 2013;98(10):828\u201330.","journal-title":"Arch Dis Child"},{"issue":"5","key":"879_CR30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000658-198611000-00001","volume":"204","author":"PH Halebian","year":"1986","unstructured":"Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg. 1986;204(5):503\u201312.","journal-title":"Ann Surg"},{"issue":"3","key":"879_CR31","first-page":"273","volume":"180","author":"JJ Kelemen 3rd","year":"1995","unstructured":"Kelemen 3rd JJ, Cioffi WG, McManus WF, Mason Jr AD, Pruitt Jr BA. Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg. 1995;180(3):273\u20138.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"879_CR32","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1074\/jbc.M606262200","volume":"282","author":"O Stojadinovic","year":"2007","unstructured":"Stojadinovic O, Lee B, Vouthounis C, Vukelic S, Pastar I, Blumenberg M, et al. Novel genomic effects of glucocorticoids in epidermal keratinocytes \u2013 inhibition of apoptosis, interferon-\u03b3 pathway, and wound healing along with promotion of terminal differentiation. J Biol Chem. 2007;282(6):4021\u201334.","journal-title":"J Biol Chem"},{"issue":"2","key":"879_CR33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/bcmd.2002.0555","volume":"29","author":"SJ Posadas","year":"2002","unstructured":"Posadas SJ, Torres MJ, Mayorga C, Juarez C, Blanca M. Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs. Blood Cell Mol Dis. 2002;29(2):179\u201389.","journal-title":"Blood Cell Mol Dis"},{"issue":"5","key":"879_CR34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s10875-008-9207-2","volume":"28","author":"C Qian","year":"2008","unstructured":"Qian C, Chen SX, Yao DK, Wu CY, Jiang TW, Ke JS, et al. Increased granulysin expression in peripheral blood cells of patients with primary biliary cirrhosis and its clinical implications. J Clin Immunol. 2008;28(5):520\u20137.","journal-title":"J Clin Immunol"},{"issue":"6","key":"879_CR35","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ajo.2008.12.040","volume":"147","author":"Y Araki","year":"2009","unstructured":"Araki Y, Sotozono C, Inatomi T, Ueta M, Yokoi N, Ueda E, et al. Successful treatment of Stevens\u2013Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol. 2009;147(6):1004\u201311. 1011 e1001.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"879_CR36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajo.2009.08.040","volume":"149","author":"MC Shammas","year":"2010","unstructured":"Shammas MC, Lai EC, Sarkar JS, Yang J, Starr CE, Sippel KC. Management of acute Stevens\u2013Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids. Am J Ophthalmol. 2010;149(2):203\u201313. e202.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"879_CR37","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","volume":"129","author":"P Joly","year":"2009","unstructured":"Joly P, Roujeau JC, Benichou J, Delaporte E, D'Incan M, Dreno B, et al. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol. 2009;129(7):1681\u20137.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"879_CR38","first-page":"243","volume":"149","author":"C Tomasini","year":"2014","unstructured":"Tomasini C, Derlino F, Quaglino P, Caproni M, Borroni G. From erythema multiforme to toxic epidermal necrolysis: same spectrum or different diseases? G Ital Dermatol Venereol. 2014;149(2):243\u201361.","journal-title":"G Ital Dermatol Venereol"},{"issue":"9","key":"879_CR39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/1346-8138.12566","volume":"41","author":"HC Tseng","year":"2014","unstructured":"Tseng HC, Wu WM, Lin SH. Staphylococcal scalded skin syndrome in an immunocompetent adult, clinically mimicking toxic epidermal necrolysis. J Dermatol. 2014;41(9):853\u20134.","journal-title":"J Dermatol"},{"issue":"5","key":"879_CR40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346(5):321\u20137.","journal-title":"N Engl J Med"},{"issue":"6","key":"879_CR41","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0738-081X(00)00188-7","volume":"19","author":"A Claudy","year":"2001","unstructured":"Claudy A. Evaluation of the safety and efficacy of a potent topical cortico-steroid in the treatment of bullous pemphigoid. Clin Dermatol. 2001;19(6):778\u201380.","journal-title":"Clin Dermatol"},{"issue":"1\u20132","key":"879_CR42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-0031-x","volume":"33","author":"JH Lin","year":"2007","unstructured":"Lin JH, Dutz JP, Sontheimer RD, Werth VP. Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol. 2007;33(1\u20132):85\u2013106.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"879_CR43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archderm.106.4.599c","volume":"106","author":"LW Gardner","year":"1972","unstructured":"Gardner LW, Acker DW. Triamcinolone and pyoderma gangrenosum. Arch Dermatol. 1972;106(4):599\u2013600.","journal-title":"Arch Dermatol"},{"issue":"4","key":"879_CR44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0190-9622(83)70172-6","volume":"9","author":"JL Jennings","year":"1983","unstructured":"Jennings JL. Pyoderma gangrenosum: successful treatment with intralesional steroids. J Am Acad Dermatol. 1983;9(4):575\u201380.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"879_CR45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","volume":"26","author":"YS Chang","year":"2007","unstructured":"Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM. Erythema multiforme, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea. 2007;26(2):123\u20139.","journal-title":"Cornea"},{"issue":"2","key":"879_CR46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1542-0124(12)70273-2","volume":"6","author":"DG Gregory","year":"2008","unstructured":"Gregory DG. The ophthalmologic management of acute Stevens\u2013Johnson syndrome. Ocul Surf. 2008;6(2):87\u201395.","journal-title":"Ocul Surf"},{"issue":"5","key":"879_CR47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","volume":"62","author":"LW Yip","year":"2007","unstructured":"Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, et al. Ocular manifestations and complications of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy. 2007;62(5):527\u201331.","journal-title":"Allergy"},{"issue":"8","key":"879_CR48","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","volume":"91","author":"MV Rojas De","year":"2007","unstructured":"De Rojas MV, Dart JK, Saw VP. The natural history of Stevens\u2013Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol. 2007;91(8):1048\u201353.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"879_CR49","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-3083.2010.03935.x","volume":"25","author":"C Ferrandiz-Pulido","year":"2010","unstructured":"Ferrandiz-Pulido C, Garcia-Fernandez D, Dominguez-Sampedro P, Garcia-Patos V. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a University Hospital. J Eur Acad Dermatol Venereol. 2010;25(10):1153\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"879_CR50","first-page":"e121","volume":"18","author":"BR Pozzo-Magana Del","year":"2011","unstructured":"Del Pozzo-Magana BR, Lazo-Langner A, Carleton B, Castro-Pastrana LI, Rieder MJ. A systematic review of treatment of drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol. 2011;18:e121\u2013133.","journal-title":"J Popul Ther Clin Pharmacol."},{"issue":"6","key":"879_CR51","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/09546634.2012.755252","volume":"25","author":"S Decani","year":"2014","unstructured":"Decani S, Federighi V, Baruzzi E, Sardella A, Lodi G. Iatrogenic Cushing\u2019s syndrome and topical steroid therapy: case series and review of the literature. J Dermatolog Treat. 2014;25(6):495\u2013500.","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"879_CR52","first-page":"882","volume":"12","author":"S Silver","year":"2013","unstructured":"Silver S, Tuppal R, Gupta AK, Clonier F, Olesen M, Leeder R, et al. Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial. J Drugs Dermatol. 2013;12(8):882\u20137.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"879_CR53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.annder.2010.03.015","volume":"137","author":"Z Boughrara","year":"2010","unstructured":"Boughrara Z, Ingen-Housz-Oro S, Legrand P, Duong TA, Roujeau JC. Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids. Ann Dermatol Venereol. 2010;137(5):345\u201351.","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"879_CR54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaad.2014.04.044","volume":"71","author":"A Paradisi","year":"2014","unstructured":"Paradisi A, Abeni D, Bergamo F, Ricci F, Didona D, Didona B. Etanercept therapy for toxic epidermal necrolysis. J Am Acad Dermatol. 2014;71(2):278\u201383.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"879_CR55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2340\/00015555-1238","volume":"92","author":"KA Pallesen","year":"2012","unstructured":"Pallesen KA, Robinson S, Toft P, Andersen KE. Successful treatment of toxic epidermal necrolysis\/Stevens\u2013Johnson syndrome overlap with human granulocyte colony stimulating factor: a case report. Acta Derm Venereol. 2012;92(2):212\u20133.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"879_CR56","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","volume":"48","author":"JM Arevalo","year":"2000","unstructured":"Arevalo JM, Lorente JA, Gonzalez-Herrada C, Jimenez-Reyes J. Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma. 2000;48(3):473\u20138.","journal-title":"J Trauma"},{"issue":"4","key":"879_CR57","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/pde.12029","volume":"31","author":"V Scott-Lang","year":"2014","unstructured":"Scott-Lang V, Tidman M, McKay D. Toxic epidermal necrolysis in a child successfully treated with infliximab. Pediatr Dermatol. 2014;31(4):532\u20134.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"879_CR58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000098164","volume":"20","author":"RC Gorne","year":"2007","unstructured":"Gorne RC, Greif C, Metzner U, Wigger-Alberti W, Elsner P. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers. Skin Pharmacol Physiol. 2007;20(3):133\u201340.","journal-title":"Skin Pharmacol Physiol"},{"issue":"4","key":"879_CR59","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2133.2008.08436.x","volume":"158","author":"A Peserico","year":"2008","unstructured":"Peserico A, Stadtler G, Sebastian M, Fernandez RS, Vick K, Bieber T. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol. 2008;158(4):801\u20137.","journal-title":"Br J Dermatol"},{"issue":"6","key":"879_CR60","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1468-3083.2010.03845.x","volume":"25","author":"M Udompataikul","year":"2011","unstructured":"Udompataikul M, Srisatwaja W. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study. J Eur Acad Dermatol Venereol. 2011;25(6):660\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"879_CR61","unstructured":"Wananukul S, Chatproedprai S, Chunharas A, Limpongsanuruk W, Singalavanija S, Nitiyarom R, et al. Randomized, double-blind, split-side, comparison study of moisturizer containing licochalcone A and 1 % hydrocortisone in the treatment of childhood atopic dermatitis. J Med Assoc Thai. 2013;96(9):1135\u201342."},{"issue":"6","key":"879_CR62","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jaad.2014.01.898","volume":"70","author":"SR Janmohamed","year":"2014","unstructured":"Janmohamed SR, Oranje AP, Devillers AC, Rizopoulos D, van Praag MC, Van Gysel D, et al. The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2014;70(6):1076\u201382.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"879_CR63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2340\/00015555-1533","volume":"93","author":"JM Jensen","year":"2013","unstructured":"Jensen JM, Weppner M, Dahnhardt-Pfeiffer S, Neumann C, Brautigam M, Schwarz T, et al. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial. Acta Derm Venereol. 2013;93(5):515\u20139.","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"879_CR64","first-page":"1106","volume":"8","author":"JL Sugarman","year":"2009","unstructured":"Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. J Drugs Dermatol. 2009;8(12):1106\u201311.","journal-title":"J Drugs Dermatol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0879-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0879-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0879-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:03:54Z","timestamp":1498241034000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0879-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,22]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["879"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0879-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,22]]},"article-number":"374"}}